EP Patent

EP0927555A1 — Use of cyclooxygenase-2 inhibitors for the treatment and prevention of tumors, tumor-related disorders and cachexia

Assigned to Daiichi Sankyo Co Ltd · Expires 1999-07-07 · 27y expired

What this patent protects

Certain cyclooxygenase-2 inhibitors are useful for the treatment and prevention of tumours and tumour-related disorders and cachexia.

USPTO Abstract

Certain cyclooxygenase-2 inhibitors are useful for the treatment and prevention of tumours and tumour-related disorders and cachexia.

Drugs covered by this patent

Patent Metadata

Patent number: EP0927555A1
Jurisdiction: EP
Classification: —
Expires: 1999-07-07
Drug substance claim: No
Drug product claim: No
Assignee: Daiichi Sankyo Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.